Breast cancer
Nadia Harbeck(Breast Center), Fátima Cardoso(Breast Cancer Alliance), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Kathryn J. Ruddy(Mayo Clinic in Arizona), Janice Tsang(University of Hong Kong), Javier Cortés(Villa Maria Hospital), Nehmat Houssami(The University of Sydney), Frédérique Penault‐Llorca(Inserm), Philip Poortmans(University of Antwerp)
Cited by 2,927
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Breast cancer
|The Lancet|2016|2.3k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k